Seminars in Hematology
Volume 46, Supplement 2 , Pages S2-S14, January 2009

Pathobiology of Secondary Immune Thrombocytopenia

  • Douglas B. Cines

      Affiliations

    • University of Pennsylvania School of Medicine, Philadelphia, PA
    • Corresponding Author InformationAddress correspondence to Douglas B. Cines, MD, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, 513A Stellar-Chance Labs, 422 Curie Blvd, Philadelphia, PA 19104
    • ,
  • Howard Liebman

      Affiliations

    • University of Southern California, Los Angeles, CA
    • ,
  • Roberto Stasi

      Affiliations

    • Ospedale “Regina Apostolorum,” Albano Laziale, Italy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 STATEMENT OF CONFLICT OF INTEREST: The authors disclose the following: Douglas B. Cines, MD: Consultant: Amgen, GSK, Syntonix, Bayer, Genzyme, Rigel; Howard A. Liebman, MD: Consultant: Amgen, GSK, Bristol-Myers Squibb; Grant/Research: Amgen, GSK, Bristol-Myers Squibb; Roberto Stasi, MD: Honoraria: Amgen, GSK; Speakers’ Bureau: Amgen, GSK.

PII: S0037-1963(08)00204-7

doi:10.1053/j.seminhematol.2008.12.005

Seminars in Hematology
Volume 46, Supplement 2 , Pages S2-S14, January 2009

Article Tools